Cargando…

Global Research Trends on the Treatment of Diffuse Large B-Cell Lymphoma: A Bibliometric and Visualized Study

Diffuse large B-cell lymphoma (DLBCL) is the most common lymphoma subtype. Treatment of DLBCL has improved greatly in recent decades, with thousands of papers published. We conducted a bibliometric analysis of the literature on DLBCL treatment, and discussed cooperation among authors, countries, and...

Descripción completa

Detalles Bibliográficos
Autores principales: Duan, Qintong, Li, Yufeng, Ou, Lijia, Li, Yajun, Zeng, Ruolan, He, Yizi, Pan, Tao, Chen, Siwei, Chen, Huan, Zang, Hui, Zhou, Hui, Xiao, Ling
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Ivyspring International Publisher 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8990428/
https://www.ncbi.nlm.nih.gov/pubmed/35399710
http://dx.doi.org/10.7150/jca.68453
_version_ 1784683370781868032
author Duan, Qintong
Li, Yufeng
Ou, Lijia
Li, Yajun
Zeng, Ruolan
He, Yizi
Pan, Tao
Chen, Siwei
Chen, Huan
Zang, Hui
Zhou, Hui
Xiao, Ling
author_facet Duan, Qintong
Li, Yufeng
Ou, Lijia
Li, Yajun
Zeng, Ruolan
He, Yizi
Pan, Tao
Chen, Siwei
Chen, Huan
Zang, Hui
Zhou, Hui
Xiao, Ling
author_sort Duan, Qintong
collection PubMed
description Diffuse large B-cell lymphoma (DLBCL) is the most common lymphoma subtype. Treatment of DLBCL has improved greatly in recent decades, with thousands of papers published. We conducted a bibliometric analysis of the literature on DLBCL treatment, and discussed cooperation among authors, countries, and institutions, and identified research hotspots for DLBCL treatment. We searched the Web of Science Core Collection (WOSCC) using “Diffuse Large B Cell Lymphoma or DLBCL” and “Treatment or Therapy or Clinical Trial” as the subject terms, and analyzed the publication year, research direction, country/region, institution, author, source publication, distribution of funding institutions, and other conditions provided by the database. In addition, scientometrics software was used to analyze literature citations and cooperative publications. Bibliometric analyses were performed using https://bibliometric.com/app and VOSviewer. Network maps were generated to evaluate collaborations between different authors, countries, institutions, and keywords. A total of 7,255 studies on treatment of DLBCL were retrieved from the WOSCC on February 19, 2021. We found that the number of publications increased gradually from 1999 to 2021, and this trend was relatively stable in the past 3 years. The countries that produced the most publications were the United States, China, and Japan. Among institutions, University of Texas MD Anderson Cancer Center published the most manuscripts. Furthermore, the United States also had the most annual publications, citations, distribution of journal sources, and funding. Cooperative research between countries is also relatively important to treatment of DLBCL. Therapeutic regimens such as CHOP and R-CHOP, and immunotherapy (CAR-T, PD1/PDL1, and CAR-NK, etc.), have received increased attention. Bibliometric analysis of studies related to DLBCL treatment can help researchers and clinical workers quickly understand the hotspots and development trends in this field, and provide reference for the formulation of public health policies.
format Online
Article
Text
id pubmed-8990428
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Ivyspring International Publisher
record_format MEDLINE/PubMed
spelling pubmed-89904282022-04-08 Global Research Trends on the Treatment of Diffuse Large B-Cell Lymphoma: A Bibliometric and Visualized Study Duan, Qintong Li, Yufeng Ou, Lijia Li, Yajun Zeng, Ruolan He, Yizi Pan, Tao Chen, Siwei Chen, Huan Zang, Hui Zhou, Hui Xiao, Ling J Cancer Research Paper Diffuse large B-cell lymphoma (DLBCL) is the most common lymphoma subtype. Treatment of DLBCL has improved greatly in recent decades, with thousands of papers published. We conducted a bibliometric analysis of the literature on DLBCL treatment, and discussed cooperation among authors, countries, and institutions, and identified research hotspots for DLBCL treatment. We searched the Web of Science Core Collection (WOSCC) using “Diffuse Large B Cell Lymphoma or DLBCL” and “Treatment or Therapy or Clinical Trial” as the subject terms, and analyzed the publication year, research direction, country/region, institution, author, source publication, distribution of funding institutions, and other conditions provided by the database. In addition, scientometrics software was used to analyze literature citations and cooperative publications. Bibliometric analyses were performed using https://bibliometric.com/app and VOSviewer. Network maps were generated to evaluate collaborations between different authors, countries, institutions, and keywords. A total of 7,255 studies on treatment of DLBCL were retrieved from the WOSCC on February 19, 2021. We found that the number of publications increased gradually from 1999 to 2021, and this trend was relatively stable in the past 3 years. The countries that produced the most publications were the United States, China, and Japan. Among institutions, University of Texas MD Anderson Cancer Center published the most manuscripts. Furthermore, the United States also had the most annual publications, citations, distribution of journal sources, and funding. Cooperative research between countries is also relatively important to treatment of DLBCL. Therapeutic regimens such as CHOP and R-CHOP, and immunotherapy (CAR-T, PD1/PDL1, and CAR-NK, etc.), have received increased attention. Bibliometric analysis of studies related to DLBCL treatment can help researchers and clinical workers quickly understand the hotspots and development trends in this field, and provide reference for the formulation of public health policies. Ivyspring International Publisher 2022-03-14 /pmc/articles/PMC8990428/ /pubmed/35399710 http://dx.doi.org/10.7150/jca.68453 Text en © The author(s) https://creativecommons.org/licenses/by/4.0/This is an open access article distributed under the terms of the Creative Commons Attribution License (https://creativecommons.org/licenses/by/4.0/). See http://ivyspring.com/terms for full terms and conditions.
spellingShingle Research Paper
Duan, Qintong
Li, Yufeng
Ou, Lijia
Li, Yajun
Zeng, Ruolan
He, Yizi
Pan, Tao
Chen, Siwei
Chen, Huan
Zang, Hui
Zhou, Hui
Xiao, Ling
Global Research Trends on the Treatment of Diffuse Large B-Cell Lymphoma: A Bibliometric and Visualized Study
title Global Research Trends on the Treatment of Diffuse Large B-Cell Lymphoma: A Bibliometric and Visualized Study
title_full Global Research Trends on the Treatment of Diffuse Large B-Cell Lymphoma: A Bibliometric and Visualized Study
title_fullStr Global Research Trends on the Treatment of Diffuse Large B-Cell Lymphoma: A Bibliometric and Visualized Study
title_full_unstemmed Global Research Trends on the Treatment of Diffuse Large B-Cell Lymphoma: A Bibliometric and Visualized Study
title_short Global Research Trends on the Treatment of Diffuse Large B-Cell Lymphoma: A Bibliometric and Visualized Study
title_sort global research trends on the treatment of diffuse large b-cell lymphoma: a bibliometric and visualized study
topic Research Paper
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8990428/
https://www.ncbi.nlm.nih.gov/pubmed/35399710
http://dx.doi.org/10.7150/jca.68453
work_keys_str_mv AT duanqintong globalresearchtrendsonthetreatmentofdiffuselargebcelllymphomaabibliometricandvisualizedstudy
AT liyufeng globalresearchtrendsonthetreatmentofdiffuselargebcelllymphomaabibliometricandvisualizedstudy
AT oulijia globalresearchtrendsonthetreatmentofdiffuselargebcelllymphomaabibliometricandvisualizedstudy
AT liyajun globalresearchtrendsonthetreatmentofdiffuselargebcelllymphomaabibliometricandvisualizedstudy
AT zengruolan globalresearchtrendsonthetreatmentofdiffuselargebcelllymphomaabibliometricandvisualizedstudy
AT heyizi globalresearchtrendsonthetreatmentofdiffuselargebcelllymphomaabibliometricandvisualizedstudy
AT pantao globalresearchtrendsonthetreatmentofdiffuselargebcelllymphomaabibliometricandvisualizedstudy
AT chensiwei globalresearchtrendsonthetreatmentofdiffuselargebcelllymphomaabibliometricandvisualizedstudy
AT chenhuan globalresearchtrendsonthetreatmentofdiffuselargebcelllymphomaabibliometricandvisualizedstudy
AT zanghui globalresearchtrendsonthetreatmentofdiffuselargebcelllymphomaabibliometricandvisualizedstudy
AT zhouhui globalresearchtrendsonthetreatmentofdiffuselargebcelllymphomaabibliometricandvisualizedstudy
AT xiaoling globalresearchtrendsonthetreatmentofdiffuselargebcelllymphomaabibliometricandvisualizedstudy